Discover exclusive news, ideas and insights from across the spectrum of healthcare innovation.

How will you advance healthcare?

Regular

Expert panel explores patient experiences with GLP-1 and the future of obesity treatments at Biotech Showcase 2025.

Reality Check: Doctors Challenge GLP-1 "Magic Drug" Narrative 

ARPA-H streamlined application and 30-minute pitches aid funding for academic and industry healthcare innovators.

ARPA-H Gives Startups Fast Cash with Few Strings to Transform Health media

ARPA-H Gives Startups Fast Cash with Few Strings to Transform Health

To understand GLP-1s use for weight loss, CURE surveyed current and former patients about their attitudes and experience.

Patients Use GLP-1 Drugs for Weight Loss, Gaining Benefits

thumbnail_GLP1RA_patients_survey_GTY2025837217

Patients' Use GLP-1 Drugs for Weight Loss, Benefit Gains

To understand current prescribing practices for off-label use of GLP-1Rs, CURE surveyed physicians across the specialties of gastroenterology, addiction medicine, cardiology, neurology and orthopedics.

Specialty Physicians on Using GLP-1 Drugs Off Label 

What biopharma innovations are capturing investors’ attention at the 2025 JP Morgan Healthcare Conference? 

What to Expect from Healthcare Investments in 2025 image

What to Expect from Healthcare Investments in 2025

Only a third of patients needing new hearts, lungs, livers, and kidneys get one. Why is there a transplantation gap in the United States, and can new technology and new policies help?

Addressing US Organ Shortage: Insights from Arthur Caplan image

Addressing US Organ Shortage: Insights from Arthur L. Caplan, PhD

Lexeo Therapeutics is innovating not just genetic modifications as therapies for target diseases, but also manufacturing and clinical studies.

Lexeo Applies Gene Therapy to Alzheimer’s and Heart Diseases

Elektra Health is transforming menopause care with personalized, evidence-based virtual support and education, helping women lead healthier, more productive lives.

tuesday-talks-alessandra-henderson-mba

Revolutionizing Menopause Care: Elektra Health Leads the Way

Shalabh Gupta, MD, CEO and founder of Unicycive Therapeutics, is on a mission to revolutionize kidney disease care by changing drug formulation to address the overwhelming number of daily pills patients must take.

How can Nanoparticles Transform Kidney Disease Care

Angel investor and pharma industry executive-turned-consultant Shwen Gwee has worked with startups for more than 15 years, garnering insights for biopharma entrepreneurs.

5 Startup Funding Tips from Angel Investor Shwen Gwee

Unlocking the body's electrical communication might make medicine look more like an electrician's toolkit and offer potential solutions for chronic inflammatory conditions.

Bioelectronic Medicine Gains Wider Acceptance

José Manuel (Manny) Otero, PhD, Chief Technical Officer at Lexeo Therapeutics shares a roadmap for early-stage biotechs.

Biotech Expert Manny Otero, PhD, on Trends Shaping Startups

Technology can improve patient care, bulk up healthcare system operations and finances, and support value-based care initiatives.

General Catalyst Brings Disruptive Change to Healthcare

With a proven track record of driving innovation, scaling companies, and navigating complex regulatory landscapes, Anderson continues to lead the charge in making personalized diagnostics a reality for people worldwide.

Bonnie Anderson: Innovator of Genomic Diagnostics

Funding of neuro research accelerates new targets and technologies for Alzheimer’s.

‘Neuro-Curious’ VCs Prompt Optimistic Alzheimer's Outlook

The successful treatment of patients with IBD, such as ulcerative colitis or Crohn's disease, might be transformed by Insilico’s ISM5411.



AI-Designed Therapy for Inflammatory Bowel Disease Advances

James Huang, MBA, of Panacea Venture offers advice about what's essential for biotech entrepreneurs to know when preparing to launch a startup.

James Huang, MBA

4 Tips for Biotech Startups: Panacea Venture's James Huang

National Academies’ groundbreaking report calls for $15.7 billion in Congressional funding to foster interdisciplinary women’s health research and scientific careers.

NIH Recommended to Create New Institute for Women’s Health 

Investing in making preclinical cancer research smarter through better use of technology and data translation could improve innovation of therapies.

image_cancer_destruction_concept_GTY_903389580

Breaking Cancer’s Breakthrough Bottleneck 

Hockfield's status as a biologist at the helm of a predominantly engineering-focused institution reshaped MIT’s trajectory in science and entrepreneurship.

tuesday-talks-susan-hockfield-phd

Susan Hockfield's MIT Legacy: Building a Biotech Ecosystem

Sex is a biological variable in the development and expression of neurological diseases like multiple sclerosis, stroke and Alzheimer's disease.

image_brain_cancer_neurology_woman_GTY1190676244

How Neurological Diseases Differ in Women

Federer’s approach focuses on high-potential areas like brain health and autoimmune conditions, where new research reveals significant gender-based differences.

Jessica-federer-biofutures-2024

Jessica Federer's Investment Vision for Women’s Health

Using machine learning to take on drug overdoses earned Dean Wang a finalist position in the 2024 BioGENEius Challenge

 2024 BioGENEius Challenge Finalist Dean Wang

Spotlight on 2024 BioGENEius Challenge Finalist: Dean Wang

ARPA-H Director Renee Wegrzyn, PhD, joins Cure CEO Seema Kumar in showcasing Ancilia Biosciences, Aspira Women's Health, Celmatix, Gameto and Glaucus

arpa-h-celebrates-sprint-for-womens-health 

Cure Event Honors ARPA-H Sprint for Women's Health Awardees

Cure released its 2024 Women’s Health Benchmark Report, "Unlocking the Opportunity: What's Needed to Innovate, Invest and Impact Women's Health." The report found that as women’s health grows in the biopharma sector, established scientific expertise, robust clinical data and previous commercial experience are the key success factors to raising capital. However, for women’s health to realize its trillion-dollar opportunity, closing the significant gap in data on how sex as a biological variable differentially impacts the health of women is a challenging but essential step.

WHAT INVESTORS LOOK FOR IN FUNDING WOMEN’S HEALTH image article

Cure releases 2024 Women’s Health Benchmark Report

Stacey Seltzer evaluates women's health investments, looking for opportunities others missed. 

Building the Women's Health Case: A Veteran Investor's Vision

Stella Vnook, PhD, is a serial entrepreneur who brings deep scientific and business expertise to cancer drug development

Shadow of Chernobyl Drives Innovation in Women's Cancer Treatment

Realizing there's more than reproductive medicine when thinking of the health of women.

Beyond 'Bikini Areas': Investors Wake Up to Women's Health image

Beyond 'Bikini Areas': Investors Wake Up to Women's Health

Developing a novel soft-robotics system to take on bed sores earned Porter Mikesell a finalist position in the 2024 BioGENEius Challenge. 

Spotlight on 2024 BioGENEius Challenge Finalist: Porter Mikesell

thumbnail-Woman-applying_glucose-sensor-GTY 1871099613

Converging ‘Unsexy’ Tech and Bio to Transform Healthcare

Panacea Venture nurtures groundbreaking companies from bench science to commercial stage, driving advancements in every aspect — from discovery to development to delivery to patients.

Panacea Venture’s Investment Approach Spurs Biotech Growth

Public Health Thank You Day, spearheaded by Research!America and leading public health organizations, recognizes those who safeguard our communities' health. 

Public Health thank you day

5 Things to Know about Public Health Thank You Day 

Novel research exploring sustainable plastic degradation garnered high schooler Sanan Khairabadi a finalist position in the 2024  BioGENEius Challenge.

BioGENEius finalist Sanan Khairabadi

Spotlight on 2024 BioGENEius Challenge Finalist: Sanan Khairabadi

Award-winning journalist and cancer survivor creates Cancer Vaccine Coalition

thumbnail_krysten_dalhgren_thames

Kristen Dahlgren’s Journey to Cancer Vaccine Advocate

Metallomix co-founder Sergei Petukhov, DVM, shares startup tips for biotech entrepreneurs.

Pioneering Biotech Metallomix’s Strategic Advice for Startups image

Pioneering Biotech Metallomix’s Strategic Advice for Startups

The legislation could prohibit U.S. pharmaceutical and biotechnology companies from contracting with certain Chinese companies.

thumbnail_medical_innovation_concept_GTY-609945312

Will the BIOSECURE Act Stall Biopharma Progress?

Kevin Tracey, MD, co-founder of SetPoint Medical, shares how a novel vagus nerve stimulation device may help patients with  Crohn's, rheumatoid arthritis or multiple sclerosis

How a Tiny Implant Could Derail Inflammatory Diseases image

How a Tiny Implant Could Derail Inflammatory Diseases

Developing a novel noninvasive and environmentally friendly approach to treat waste spills in Florida earned high schooler Anagha Iyer finalist honors in the 2024 BioGENEius Challenge.

Anagha Iyer

Spotlight on 2024 BioGENEius Challenge Finalist: Anagha Iyer

Evommune, Inc., a clinical-stage biotech and Cure Collaboration Residency company, secured $115 million in Series C financing, underscoring its pioneering approach to developing novel therapies for chronic inflammatory diseases.

Evommune $115M Series C Funding Fuels Innovation in Chronic Inflammation

Stephen K. Klasko, MD, MBA, has spent most of his career as a protagonist of transformation within large healthcare systems .

Stephen K. Klasko, MD, MBA

Stephen Klasko on Disrupting Healthcare Systems to Improve 

Insilico Medicine reports its investigational SM001-055 - the first drug designed using generative AI - had encouraging topline results in a phase 2A clinical trial.

First AI-Designed Drug Improves IPF Lung Function

To Greg Simon, former leader of President Biden's Cancer Moonshot, saving lives hinges less on new technologies and more on the effective access to existing ones.

thumbnail_telemedicine_tablet_pc

Simon Calls for Healthcare Reform Focused on Accessibility

Developing and validating a novel gene switch, "TREAD," to enhancing CRISPR-based therapies earned high schooler Yifan Ding top honors in the 2024 BioGENEius Challenge,

Spotlight on 2024 BioGENEius Challenge Winner: Yifan Ding

As artificial intelligence changes health, environmental tech and robotics, experts predict longer lives, cleaner air and humanoids

How will AI Transform the Way We Live and Breathe

CobiCure MedTech, a Collaboration Resident company at Cure, is a nonprofit advancing innovation of urgently needed pediatric medical devices.

CobiCure MedTech Helps Mend Tiny Hearts

Despite women making up more than half of the population, advancements in women’s health remain overlooked and underfunded. Here’s why.

thumbnail_boardroom_woman_business

5 Things Needed for Femtech to Flourish

Eyal Zimlichman, MD, Chief Transformation Officer and Chief Innovation Officer at Sheba Medical Center in Israel shared his optimism about the future of healthcare.


thumbnail_Zimlichman: Six Ways to Enhance Future Healthcare

Eyal Zimlichman: Six Ways to Enhance Future Healthcare Services

Working with his Einstein colleagues, Nicholas Sibinga, MD, earned a 2022 XSeed Award for identifying a protein pathway with potential to help prevent devastating neurodegenerative diseases including multiple sclerosis and ALS.

Nicholas Sibinga, MD

New Approach for Neurodegenerative Diseases like MS and ALS  

The annual BioGENEius Challenge, an esteemed competition for young talent in biotechnology from across the US, announced its 2024 winner, which Cure sponsored.

Yifan Ding Wins 2024 BioGENEius Challenge Sponsored by Cure

Manolis Kellis, PhD, discusses how artificial intelligence is transforming the very nature of medicine. 

Big genomic data visualization

Outside Lander's Office: From DNA Sequencing to AI Insights 

Metallomix combines biochemistry and biophysics to leverage the body’s "metallome," and its broader molecular networks and other "omes" — such as the genome, proteome and microbiome.

Metallomix: The Biotech Transforming Disease with Metal-Based Therapies

Former White House Coronavirus Response Coordinator Deborah L. Birx, MD, discussed key successes and critical gaps in handling the COVID-19 pandemic and how they help prepare us for next time.

COVID-19 Lessons: Preparing for Future Pandemics 

The second annual Life Sciences Day, including events at Cure, brought 250 high school students from across New York City the opportunity to explore the world of life science innovation. 

The second annual Life Sciences Day, including events at Cure, brought 250 high school students from across New York City the opportunity to explore the world of life science innovation on Oct. 24, 2024. 

Second Annual Life Sciences Day Inspires NYC High School Students

What obstacles must be overcome for disruptive tools like AI, VR and robotics to reshape healthcare as we know it? Daniel Kraft, MD, explains.

Unlocking the Future of Healthcare: How AI, VR, and Robotics will Reshape Medicine

Cure and Bayer collaborated to address the burgeoning world movement of self-care — helping people help themselves to stay healthy and make preventive care a reality.

thumbnail-bayer-event-daniella-foster

Radical Self-Care: Equitably Empowering People to Care for Themselves

Kristen Dahlgren, Founder and CEO of the Cancer Vaccine Coalition, discusses groundbreaking efforts to speed cancer vaccines, starting with breast cancer. 

How the Cancer Vaccine Coalition Pushes Life-Saving Science Forward

Rick Weissenstein, Managing Director at TD Cowen, shared his insights on how the outcome of the US presidential election will shape healthcare policy and innovation landscape.

2024 U.S. Election: How Harris or Trump Could Shape Healthcare Policy, Pricing and Innovation

Mosquito-borne diseases threaten lives and livelihoods, physicians and the public differ on views of these public health threats.

thumbnail_infographic_mosquito-borne-diseases

Mosquito-Borne Diseases: Critical Disconnects Between Physicians and Public

Arne Gennerich, PhD, Professor of Biochemistry at the Albert Einstein College of Medicine and a 2022 XSeed Award winner, is racing to develop a treatment for patients with rare genetic neurological disorders known as KAND. 

xseed-past-winner-arne_gennerich

KIF1A Gene Research Advances Rare Neurological Disorder Treatment

thumbnail_collage_faces_sunburst_GT_643999899

Aspen Institute Science & Society Program on Future of Healthcare

Evommune, led by CEO Luis Peña, is on a mission of tackle one of the world’s leading root cause of deaths: chronic inflammation, which is linked to more than 100 autoimmune diseases.

thumb_luis_pena_evommune

How Evommune is Redefining Treatments for Chronic Inflammatory and Autoimmune Diseases

Researchers at Baylor College of Medicine are developing a novel genomics surveillance program to track any infectious disease parasites transmitted by mosquitoes. The information could focus mosquito-control and disease-prevention efforts.

thumb_black_white_spotted_mosquito_surface_water

Genomic Surveillance: New Mosquito Monitoring Program to Track Emerging Diseases Amid Rising Climate Threats

World Mental Health Day 2024, October 10, focuses on "It is Time to Prioritize Mental Health in the Workplace."

thumbnail_husseini_manji_1200x675

Prioritizing Mental Health in the Workplace

Infectious disease experts critically differ in awareness, concern and reaction to the surge of mosquito-borne diseases from those on the front line, both primary care physicians and the public, finds Cure's Mosquito-Borne Diseases Benchmark Report 2024.

Uninformed, Unconcerned: Ignoring the Global Surge of Mosquito-Borne Diseases at Our Peril

The FDA recently announced a newRare Disease Innovation Hub, designed to expedite development and approval of new treatments for patients with rare diseases. Cure Xchange Challenge winner Every Cure weighs in.

Every Cure’s Grant Mitchell on Hopes and Challenges for the FDA’s New Rare Disease Hub

George Vradenburg, Chairman and Co-Founder of UsAgainstAlzheimer's, shares his optimism about advances in Alzheimer’s research, including new diagnostics and progress for a future vaccine.

Five New Advances in Alzheimer’s: Early Detection, Risk Reduction and Maybe a Future Vaccine

XSeed Award winner Andras Fiser, PhD, is working to speed detection of antibiotic-resistant bacteria and selection of their best treatment to save lives.  

XSeed Past Winner Andras Fiser

The Race to Identify Treatments to Fight SuperBugs

The new, interdisciplinary conference focuses on a bold reimagining of breast cancer prevention and treatment.

Inaugural RISE UP for Breast Cancer Meeting Planned for November 1 to 3

Alex Zhavoronkov, PhD, CEO of Insilico Medicine, — one of the world's top generative AI drug discovery companies,  shares his top five tips for biotech startup entrepreneurs on how to maximize success.

Five Tips for Entrepreneurs from Alex Zhavoronkov, PhD, CEO of Insilico Medicine Image

Five Tips for Entrepreneurs from Alex Zhavoronkov, PhD, CEO of Insilico Medicine

Five science and industry experts shared their predictions during #GenAI4Pharma NYC on how AI will transform life science research to save time, money — and lives. 

Near-Future Promises for Healthcare AI, According to 5 Experts Image

Near-Future Promises for Healthcare AI, According to 5 Experts

The adaptive clinical trial platform known as I-SPY leverages biomarkers to innovate the testing novel breast cancer treatments.

I-SPY’s Innovative New Norms for Testing Breast Cancer Treatments Image

I-SPY’s Innovative New Norms for Testing Breast Cancer Treatments

Advocating health policy, economics and technology for US  hospitals is a role Charles N. "Chip" Kahn, III, MPH, readily takes on as President and CEO of the Federation of American Hospitals.

thumbnail_laser_mri_cat_scan

Chip Kahn Advocates for American Healthcare and Hospitals

With the help of a 2023 XSeed Award, Rohini Kavlakuntla, MSc, and her two graduate school buddies are advancing the work of their startup Helex to make genetic medicine accessible and affordable for those with debilitating kidney diseases.

xseed-past-winner-rohini_kalvakuntla

From Friends to Founders: On a Mission to Combat Kidney Disease

New technologies for preserving organs could reduce wait times and make transplantation a realistic option for more patients.

thumbnail organ transplantation white paper image asset

White Paper Improving Organ Transplantation with New Technology Thumbnail

Reducing Wait Times for Organ Transplantation with New Technology

tues-talks-one-organizations-fight-cure-alzheimers

8 Things to Know About UsAgainstAlzheimer’s

Top U.S. academic life science researchers report near universal interest in translating their innovations to bring more cures to market, yet the majority also want external resources and allies for the journey, reports the 2024 Cure Translational Research Survey.

Fueling Engines of Innovation Image Asset

Fueling Engines of Innovation Image

Fueling Engines of Innovation

Suja Mathew, MD, EVP and Chief Clinical Officer of Atlantic Health System, is helping steer its vision to move beyond traditional hospital walls and focus on whole-patient care.

Transforming Healthcare with Whole-Patient Care Approach

What's new

Blue

Explore the latest insights in healthcare innovation, featuring articles on cutting-edge research, trends, and success stories from industry leaders.

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

How will you advance healthcare?

What's new

Featured

Reality Check: Doctors Challenge GLP-1 "Magic Drug" Narrative

Cure's White Papers

Featured

Patients' Use GLP-1 Drugs for Weight Loss, Benefit Gains

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Be part of Cure.

All floors are lab-ready and cabled for digital health.

A place to Succeed.

Where scientists, entrepreneurs and visionaries converge.

Cure Events.

Critical Discussions Advancing Healthcare

Cure Tuesday Talks

Tuesday Talks

Connect with Opportunity.

Two awards up to $250,000

In-depth Insights.

A Bionic Pancreas that will Help Parents Sleep More Peacefully

How will you advance healthcare?

What's new

Featured

Reality Check: Doctors Challenge GLP-1 "Magic Drug" Narrative

Cure's White Papers

Featured

Patients' Use GLP-1 Drugs for Weight Loss, Benefit Gains

Now showing

Tuesday Talks: Navigating the Entrepreneurial Ecosystem

Streaming now

Cure Events.

Cure Tuesday Talks

In-depth Insights.